Clinical Data Management Seminar 2018

  • 1295.00 Dollar US$
  • Published date: July 5, 2018
    • New Orleans, lousiana, United States

When new drugs or devices are tested in humans, the data generated by, and related to, these trials is known as clinical data. This data represents a huge investment by the biopharmaceutical or device company and is one of its greatest assets. It is this data that will eventually make a new product both useful as a treatment or therapy and marketable. The management of clinical data, from its collection during a trial to its extraction for analysis, has become a critical element in the steps to prepare a regulatory submission and to obtain approval to market a treatment. As its importance has grown, clinical data management (CDM) has changed from an essentially clerical task in the late 1970s and early 1980s to the highly computerized specialty it is today.

This seminar is based on the current state of regulations and will cover the essential parts of the data management plan, study startup, study conduct, study closeout and study monitoring.

A data management plan or DMP is a formal document that outlines how data are to be handled both during a research project, and after the project is completed. The goal of a data management plan is to consider the many aspects of data management, metadata generation, data preservation, and analysis before the project begins; this ensures that data are well-managed in the present, and prepared for preservation in the future.

Study startup activities include designing case report forms (CRFs), paper or computer; specifying cleaning rules (edit checks); building and testing the database; and releasing the study database to collect data.

Study conduct activities include collecting the data on CRFs and via electronic files, cleaning that data, managing adverse event and serious adverse event collection, and producing reports.

Study closeout focuses on ensuring the data is complete and of a quality to support final analysis.

Study monitoring is an in-person evaluation carried out by sponsor personnel or representatives at the sites at which the clinical investigation is being conducted. On-site monitoring can identify data entry errors (e.g., discrepancies between source records and case report forms (CRFs)) and missing data in source records or CRFs; and assess compliance with the protocol and investigational product

https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901825SEMINAR?science-marketplace

Price: $1,295.00 (Seminar Fee for One Delegate) Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)* Register for 10 attendees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*

Result 0 votes
John Robinson
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Recombinant EBV Protein [His]

    Recombinant EBV Protein [His]

    Clinical Shirley (New York) May 30, 2019 10.00 Dollar US$

    The Epstein–Barr virus (EBV), also called human herpesvirus 4 (HHV-4), is named after Michael Anthony Epstein. It is one of the eight known human herpesvirus types in the herpes family, and is common in human diseases. It is best known as the cause o...

  • FDA's New Enforcement of 21 CFR Part 11

    FDA's New Enforcement of 21 CFR Part 11

    Clinical Fremont (California) May 23, 2019 190.00 Dollar US$

    Overview: The webinar will have the answers. And using industry proven case studies on how to avoid 483 inspectional observations and warning letters attendees will learn how to prepare their organization for trouble-free Part 11 related inspections....

  • Inactivated RSV Antigen

    Inactivated RSV Antigen

    Clinical Shirley (New York) April 28, 2019 10.00 Dollar US$

    Human respiratory syncytial virus (HRSV) belongs to Paramyxoviridae family. It is a syncytial virus that causes respiratory tract infections. RSV is an enveloped RNA virus with a non-segmented single-stranded negative-sense genome. The disease caused...